Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 32,341 VRDN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 32,341 | n/a |
| Jun 11, 2026 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 34,843 | n/a |
| Jun 11, 2026 | Cogent Biosciences, Inc. (COGT) | Grant/Award | 17,901 | n/a |
| Mar 25, 2026 | Damora Therapeutics, Inc. (DMRA) | Grant/Award | 37,313 | n/a |
| Jul 2, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 21,000 | n/a |
| Jun 5, 2025 | Cogent Biosciences, Inc. (COGT) | Grant/Award | 44,700 | n/a |
| May 1, 2025 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 23,017 | n/a |
| Mar 12, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 42,000 | n/a |
| Jun 13, 2024 | Cogent Biosciences, Inc. (COGT) | Grant/Award | 44,700 | n/a |
| Jun 8, 2023 | Cogent Biosciences, Inc. (COGT) | Grant/Award | 36,700 | n/a |